& Dobbins, J
"It also points to the need for better strategies to make these treatments more accessible and available to those who need them.However, researchers noted that larger studies involving more women are needed to confirm their findings and figure out why hormone therapy might boost GLP-1 drug effectiveness.Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.More information The Mayo Clinic has more on menopause hormone therapy.SOURCE: The Endocrine Society, news release, July 12, 2025 .What This Means For YouWomen should talk to their doctor about using menopause hormone therapy and GLP-1 drugs..Sign up for our weekly HealthDay newsletter
For people with obesity or overweight-related metabolic disease, yesevidence supports long-term or indefinite therapy, similar to diabetes or hypertension management
Medication Options Offering both compounded semaglutide and tirzepatide plus access to brand-name Wegovy and Zepbound (when available) gives Yucca Health broader options than some platforms that only offer one active ingredient
As scientific understanding of obesity, insulin signaling, and hormonal regulation continues to evolve, compounds like Retatrutide may contribute valuable insights into future therapeutic research pathways
Enough consistency to trust the process